Edwards Lifesciences (EW) Finished Goods (2010 - 2026)

Edwards Lifesciences has reported Finished Goods for 13 years, with the latest figure at $674.4 million in Q1 2026.

• For the quarter ending Q1 2026, Finished Goods rose 13.44% year-over-year to $674.4 million; the trailing twelve-month figure through Mar 2026 stood at $674.4 million (up 13.44% YoY), and the FY2025 full-year result was $676.7 million, up 11.04% from the prior year.
• Finished Goods for Q1 2026 stood at $674.4 million, roughly flat from $676.7 million in the prior quarter.
• The five-year high for Finished Goods was $676.7 million in Q4 2025, with the low at $511.4 million in Q4 2023.
• Average Finished Goods over 4 years is $617.2 million, with a median of $620.8 million recorded in 2024.
• Year-over-year, Finished Goods advanced 19.16% in 2024 and decreased 11.1% in 2025.
• Tracing EW's Finished Goods over 4 years: stood at $511.4 million in 2023, then increased by 19.16% to $609.4 million in 2024, then advanced by 11.04% to $676.7 million in 2025, then declined by 0.34% to $674.4 million in 2026.
• The last three Finished Goods figures came in at $674.4 million (Q1 2026), $676.7 million (Q4 2025), and $642.2 million (Q3 2025), per Business Quant data.

Peer Comparison